Live Breaking News & Updates on Beebe Devarney

Stay updated with breaking news from Beebe devarney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioCorRx Reports Business Update for the First Quarter of 2024

May 16, 2024 - BioCorRx Inc. , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the three months ended March. ....

United States , Lourdes Felix , Kate Beebe Devarney , National Institutes Of Health Under Award Number , Agreement Terms , End Addiction Initiative , Development Of Medications To , Exchange Commission , Biocorrx Pharmaceuticals Board Of Directors , National Institute On Drug Abuse , Biocorrx Inc , Biocorrx Pharmaceuticals , National Institutes Of Health , Trademark Office , National Survey On Drug , Biocorrx Pharmaceuticals Inc , Uncraverx Weight Loss Program , Corrx Inc , Corrx Pharmaceuticals , Drug Abuse , Beebe Devarney , Biocorrx Pharmaceuticals Board , United States Patent , Opioid Use Disorder , Corrx Pharmaceuticals Inc , End Addiction Long Term Initiative ,

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Kate Beebe Devarney , Titan Pharmaceuticals , Securities Exchange , Exchange Commission , Titan Pharmaceuticals Inc , Titan Pharmaceuticals Fully Compliant With , Nasdaq Stock Market , Nasdaq Capital , South San Francisco , Securities Act , Securities Exchange Act , Annual Report , Investor Contacts , Beebe Devarney , Chief Operating ,

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 Titan Pharmaceuticals, Inc. today announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the. ....

Kate Beebe Devarney , Securities Exchange , Globenewswire Inc , Titan Pharmaceuticals Inc , Nasdaq Stock Market , Titan Pharmaceuticals , Exchange Commission , Nasdaq Capital , San Francisco , Securities Act , Securities Exchange Act , Annual Report , Investor Contacts , Beebe Devarney , Chief Operating ,

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Kate Beebe Devarney , Exchange Commission , Titan Pharmaceuticals , Titan Pharmaceuticals Inc , Titan Pharmaceuticals Announces Reverse Stock , Continental Stock Transfer Trust Company , Securities Exchange , Pharmaceuticals Announces Reverse Stock Split , Restated Certificate , Special Meeting , Nasdaq Capital Market , Continental Stock Transfer , Trust Company , South San Francisco , Securities Act , Securities Exchange Act , Annual Report , Investor Contacts , Beebe Devarney , Chief Operating ,

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kate Beebe Devarney , Titan Pharmaceuticals Inc , Continental Stock Transfer Trust Company , Titan Pharmaceuticals , Exchange Commission , Securities Exchange , Restated Certificate , Special Meeting , Nasdaq Capital Market , Continental Stock Transfer , Trust Company , South San Francisco , Securities Act , Securities Exchange Act , Annual Report , Investor Contacts , Beebe Devarney , Chief Operating ,